241 related articles for article (PubMed ID: 36342000)
1. Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.
Claes KJ; Geerts I; Lemahieu W; Wilmer A; Kuypers DRJ; Koshy P; Ombelet S
Am J Kidney Dis; 2023 Mar; 81(3):364-367. PubMed ID: 36342000
[TBL] [Abstract][Full Text] [Related]
2. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
Che M; Moran SM; Smith RJ; Ren KYM; Smith GN; Shamseddin MK; Avila-Casado C; Garland JS
Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccination and Atypical hemolytic uremic syndrome.
Bouwmeester RN; Bormans EMG; Duineveld C; van Zuilen AD; van de Logt AE; Wetzels JFM; van de Kar NCAJ
Front Immunol; 2022; 13():1056153. PubMed ID: 36531998
[TBL] [Abstract][Full Text] [Related]
4. Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.
Rysava R; Peiskerova M; Tesar V; Benes J; Kment M; Szilágyi Á; Csuka D; Prohászka Z
Front Immunol; 2022; 13():1001366. PubMed ID: 36275662
[TBL] [Abstract][Full Text] [Related]
5. Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report.
Campos MAG; Ataídes RJC; Ferreira MC; Alves AS; Silva GEB
Immun Inflamm Dis; 2024 Jul; 12(7):e1270. PubMed ID: 38967360
[TBL] [Abstract][Full Text] [Related]
6. End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision.
Moronti V; Carubbi F; Sollima L; Piscitani L; Ferri C
Medicine (Baltimore); 2023 Dec; 102(50):e36560. PubMed ID: 38115241
[TBL] [Abstract][Full Text] [Related]
7. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.
Ferrer F; Roldão M; Figueiredo C; Lopes K
Nephron; 2022; 146(2):185-189. PubMed ID: 34724668
[TBL] [Abstract][Full Text] [Related]
8. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
[TBL] [Abstract][Full Text] [Related]
9. Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report.
Bruno V; Barth D; Jauhal A
Can J Kidney Health Dis; 2023; 10():20543581231209009. PubMed ID: 37942411
[TBL] [Abstract][Full Text] [Related]
10. Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases.
Smarz-Widelska I; Syroka-Główka M; Janowska-Jaremek J; Kozioł MM; Załuska W
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141710
[TBL] [Abstract][Full Text] [Related]
11. [A hemolytic episode following COVID-19 in a case with atypical hemolytic uremic syndrome].
Suzuki K; Nagaharu K; Hachiya K; Nishimura K; Matsumoto T; Tawara I
Rinsho Ketsueki; 2022; 63(3):224-228. PubMed ID: 35387937
[TBL] [Abstract][Full Text] [Related]
12. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
[TBL] [Abstract][Full Text] [Related]
13. The roles of homocysteinemia and methylmalonic acidemia in kidney injury in atypical hemolytic uremic syndrome caused by cobalamin C deficiency.
Wood WD; Elmaghrabi A; Gotway G; Wolf MTF
Pediatr Nephrol; 2022 Jun; 37(6):1415-1418. PubMed ID: 34854955
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
[TBL] [Abstract][Full Text] [Related]
15. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
16. New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.
Ma Q; Xu G
J Med Virol; 2023 Jul; 95(7):e28946. PubMed ID: 37436788
[TBL] [Abstract][Full Text] [Related]
17. Life-Threatening Diffuse Alveolar Hemorrhage and Graft Failure in Atypical Hemolytic Uremic Syndrome with C3 Gene Mutation following Kidney Transplant.
Song JY; Oh SH; Kim Y
Nephron; 2024; 148(7):474-479. PubMed ID: 38008090
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H
Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
[TBL] [Abstract][Full Text] [Related]
19. End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report.
Tawhari M; Alhamadh MS; Alhabeeb AY; Almudayfir Z; Radwi M
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992263
[TBL] [Abstract][Full Text] [Related]
20. Atypical hemolytic uremic syndrome: a case report.
Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
